COGNITION THERAPEUTICS INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Cognition Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
  • Cognition Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 40.1M shares, a 35.3% increase year-over-year.
  • Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 30M shares, a 27% increase from 2022.
  • Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 23.6M shares, a 355% increase from 2021.
  • Cognition Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 5.19M shares, a 922% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 30M +6.39M +27% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 23.6M +18.4M +355% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 5.19M +4.68M +922% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 508K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.